People: Alkermes Plc (ALKS.OQ)
13 Sep 2019
Dr. Craig C. Hopkinson, M.D., is Senior Vice President - Medicines Development and Medical Affairs, Chief Medical Officer of the Company, since February 1, 2018. Prior to assuming his current positions, Dr. Hopkinson was our Chief Medical Officer, and Senior Vice President of Clinical Development and Medical Affairs from May 2017 to February 2018. Prior to joining the Company, Dr. Hopkinson served as Senior Vice President and Head of Global Affairs at Vertex Pharmaceuticals from July 2014 until May 2017. Prior to that, Dr. Hopkinson held various executive management positions at Eisai Pharmaceuticals, including President Eisai Value Maximization Systems from January 2013 to July 2014 and President and Chief Medical Officer from October 2011 to December 2012. Dr. Hopkinson has extensive experience in research and development, medical affairs, and with the U.S. Food and Drug Administration (the “FDA”). Dr. Hopkinson is also a member of the South African Association of Pharmaceutical Physicians.
|Total Annual Compensation,||--|
|Restricted Stock Award,||--|
|Long-Term Incentive Plans,||--|
|Fiscal Year Total,||--|